Literature DB >> 11827872

MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia.

Haruo Hanyu1, Tetsuichi Asano, Hirofumi Sakurai, Yuriko Tanaka, Masaru Takasaki, Kimihiko Abe.   

Abstract

BACKGROUND AND
PURPOSE: The substantia innominata can be visualized on coronal thin-section T2-weighted MR images. The purpose of this study was to investigate the morphologic changes of the substantia innominata in normal aging by using MR imaging and to determine whether the changes in this structure on MR images were specific to Alzheimer disease (AD).
METHODS: The thickness of the substantia innominata was measured on the coronal T2-weighted image obtained through the anterior commissure in 39 healthy control subjects (age range, 25-86 y; mean age, 62 y); 39 patients with AD; and 36 patients with non-AD dementia, including vascular dementia, frontotemporal dementia, and Parkinson disease with dementia.
RESULTS: In the control subjects, the thickness of the substantia innominata significantly decreased with age. Compared with age-matched control subjects, both patients with AD and patients with non-AD dementia had significant atrophy of the substantia innominata. The thickness of the substantia innominata significantly correlated with scores from the Mini-Mental State Examination in patients with AD but not in patients with non-AD dementia.
CONCLUSION: MR analysis reveals age-related shrinkage of the substantia innominata. Atrophy of the substantia innominata, which reflects degeneration in the nucleus basalis of Meynert, is pronounced both in patients with AD and in those with non-AD dementia. MR imaging features in this structure may not be specific to AD.

Entities:  

Mesh:

Year:  2002        PMID: 11827872      PMCID: PMC7975505     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  33 in total

Review 1.  Factors influencing contrast in fast spin-echo MR imaging.

Authors:  R T Constable; A W Anderson; J Zhong; J C Gore
Journal:  Magn Reson Imaging       Date:  1992       Impact factor: 2.546

Review 2.  Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease.

Authors:  O J Vogels; C A Broere; H J ter Laak; H J ten Donkelaar; R Nieuwenhuys; B P Schulte
Journal:  Neurobiol Aging       Date:  1990 Jan-Feb       Impact factor: 4.673

3.  Alzheimer's disease and Down's syndrome.

Authors:  D L Price; P J Whitehouse; R G Struble; J T Coyle; A W Clark; M R Delong; L C Cork; J C Hedreen
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

4.  Neuron loss in the nucleus basalis of Meynert in parkinsonism-dementia complex of Guam.

Authors:  I Nakano; A Hirano
Journal:  Ann Neurol       Date:  1983-01       Impact factor: 10.422

5.  Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis.

Authors:  P J Whitehouse; D L Price; A W Clark; J T Coyle; M R DeLong
Journal:  Ann Neurol       Date:  1981-08       Impact factor: 10.422

6.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

7.  Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

Authors:  G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

8.  Choline acetyltransferase immunohistochemistry in brains of Alzheimer's disease patients and controls.

Authors:  T Nagai; P L McGeer; J H Peng; E G McGeer; C E Dolman
Journal:  Neurosci Lett       Date:  1983-04-11       Impact factor: 3.046

9.  Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease.

Authors:  E K Perry; V Haroutunian; K L Davis; R Levy; P Lantos; S Eagger; M Honavar; A Dean; M Griffiths; I G McKeith
Journal:  Neuroreport       Date:  1994-03-21       Impact factor: 1.837

10.  Neurone loss in the nucleus basalis of Meynert in Creutzfeldt-Jakob disease.

Authors:  T Arendt; V Bigl; A Arendt
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

View more
  38 in total

1.  The magic measurement.

Authors:  J Stevens
Journal:  AJNR Am J Neuroradiol       Date:  2004-01       Impact factor: 3.825

Review 2.  Mild cognitive impairment: pathology and mechanisms.

Authors:  Elliott J Mufson; Lester Binder; Scott E Counts; Steven T DeKosky; Leyla de Toledo-Morrell; Stephen D Ginsberg; Milos D Ikonomovic; Sylvia E Perez; Stephen W Scheff
Journal:  Acta Neuropathol       Date:  2011-11-19       Impact factor: 17.088

3.  Differences in MR features of the substantia innominata between dementia with Lewy bodies and Alzheimer's disease.

Authors:  Haruo Hanyu; Yuriko Tanaka; Soichiro Shimizu; Hirofumi Sakurai; Toshiko Iwamoto; Kimihiko Abe
Journal:  J Neurol       Date:  2005-03-18       Impact factor: 4.849

4.  Atrophy of the cholinergic Basal forebrain over the adult age range and in early stages of Alzheimer's disease.

Authors:  Michel Grothe; Helmut Heinsen; Stefan J Teipel
Journal:  Biol Psychiatry       Date:  2011-08-04       Impact factor: 13.382

5.  Stereotaxic probabilistic maps of the magnocellular cell groups in human basal forebrain.

Authors:  Laszlo Zaborszky; L Hoemke; H Mohlberg; A Schleicher; K Amunts; K Zilles
Journal:  Neuroimage       Date:  2008-06-07       Impact factor: 6.556

6.  Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment.

Authors:  Michel J Grothe; Helmut Heinsen; Edson Amaro; Lea T Grinberg; Stefan J Teipel
Journal:  Cereb Cortex       Date:  2015-04-02       Impact factor: 5.357

7.  The cholinergic system in mild cognitive impairment and Alzheimer's disease: an in vivo MRI and DTI study.

Authors:  Stefan J Teipel; Thomas Meindl; Lea Grinberg; Michel Grothe; Jose L Cantero; Maximilian F Reiser; Hans-Jürgen Möller; Helmut Heinsen; Harald Hampel
Journal:  Hum Brain Mapp       Date:  2010-07-29       Impact factor: 5.038

Review 8.  Deep brain stimulation for disorders of memory and cognition.

Authors:  Tejas Sankar; Nir Lipsman; Andres M Lozano
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

9.  MRI-based volumetric measurement of the substantia innominata in amnestic MCI and mild AD.

Authors:  S George; E J Mufson; S Leurgans; R C Shah; C Ferrari; L deToledo-Morrell
Journal:  Neurobiol Aging       Date:  2009-12-14       Impact factor: 4.673

10.  Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer's disease.

Authors:  Michel Grothe; Laszlo Zaborszky; Mercedes Atienza; Eulogio Gil-Neciga; Rafael Rodriguez-Romero; Stefan J Teipel; Katrin Amunts; Aida Suarez-Gonzalez; Jose L Cantero
Journal:  Cereb Cortex       Date:  2009-11-04       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.